Clinical Trials in Herlev, Denmark
3 recruiting
Showing 1–18 of 18 trials
Recruiting
Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC1,530 enrolled281 locationsNCT06393374
Recruiting
Phase 3
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Prostate CancerProstatic Neoplasms
Merck Sharp & Dohme LLC1,440 enrolled274 locationsNCT06925737
Recruiting
Phase 3
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche600 enrolled195 locationsNCT06793215
Recruiting
Not Applicable
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
Metastatic Breast CancerResponse Monitoring
Odense University Hospital420 enrolled11 locationsNCT06877949
Recruiting
Phase 3
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Non-small Cell Lung CancerAnaplastic Lymphoma Kinase-positive
Nuvalent Inc.450 enrolled112 locationsNCT06765109
Recruiting
DESTINY Breast Respond HER2-low Europe
Metastatic Breast CancerUnresectable Breast CancerHER2-low Expressing Breast Cancer
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1,155 enrolled211 locationsNCT05945732
Recruiting
Not Applicable
Benefit of Spectral Information in Patients Suspected for Lung Cancer
Lung Neoplasm Malignant
Copenhagen University Hospital at Herlev1,000 enrolled1 locationNCT06440616
Recruiting
Not Applicable
Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer
HER2-positive Breast CancerCardiotoxicity
Odense University Hospital220 enrolled4 locationsNCT05406635
Recruiting
Phase 1Phase 2
Study of DF1001 in Patients with Advanced Solid Tumors
Solid Tumor, Adult
Dragonfly Therapeutics378 enrolled52 locationsNCT04143711
Recruiting
Not Applicable
Protons Vs. Photons for High-risk Prostate Cancer
Radiotherapy Side EffectProstate Cancer
University of Aarhus400 enrolled7 locationsNCT05350475
Recruiting
Not Applicable
High Impact Training to Patients with Prostate Cancer and Bone Metastases
Prostate Cancer
Copenhagen University Hospital at Herlev102 enrolled1 locationNCT06259279
Recruiting
Not Applicable
Cross-sectorial Rehabilitation of Patients with Lung Cancer
Lung Cancer Non-Small Cell Cancer (NSCLC)
Camilla Balle130 enrolled1 locationNCT06705465
Recruiting
Not Applicable
Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)
Pancreatic CancerLung Cancer, Nonsmall Cell
Inna Chen, MD274 enrolled1 locationNCT04611867
Recruiting
Not Applicable
Prospective Surveillance for Breast Cancer-Related Lymphedema
Breast Cancer
Rigshospitalet, Denmark250 enrolled3 locationsNCT04522648
Recruiting
Not Applicable
A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY).
Radiotherapy Side EffectLung CancerMetastases to Lung
Rigshospitalet, Denmark138 enrolled6 locationsNCT05354596
Recruiting
Not Applicable
Novel Approach to Radiotherapy in Locally Advanced Lung Cancer Concomitant Navelbine®
NSCLC
Olfred Hansen330 enrolled7 locationsNCT02354274
Recruiting
Not Applicable
The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer
Early Breast CancerRadiation Associated Cardiac Failure
Danish Breast Cancer Cooperative Group1,502 enrolled8 locationsNCT04291378
Recruiting
Not Applicable
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
Local Neoplasm RecurrenceDistantly Metastatic Malignant NeoplasmDeath+6 more
Danish Breast Cancer Cooperative Group926 enrolled17 locationsNCT03646955